Navigation Links
Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
Date:7/10/2008

ny's scientific and commercial vision, clinical development plans to proof-of-concept, and development milestones of select programs in clinical development. Some of the programs discussed included the following:

-- MDX-1106 (ONO-4538) is a fully human anti-PD-1 antibody in development with Ono Pharmaceuticals, Inc. for solid tumors. Preliminary data of anti- tumor activity in multiple tumor types from an ongoing Phase 1 trial were previously reported at a recent medical conference. A multi-dose Phase 2 study in solid tumors is expected to begin in 2008. A separate Phase 1 trial for hepatitis C viral infection is ongoing, with data expected in 2009.

-- MDX-1100 is a fully human antibody that targets IP-10, a chemokine that promotes the recruitment of pro-inflammatory cells that can cause tissue damage in rheumatoid arthritis and inflammatory bowel diseases. MDX-1100 represents a breakthrough mechanism of action for inflammatory disease and is being investigated in separate Phase 2 proof-of-concept trials for ulcerative colitis and rheumatoid arthritis. Interim data from these trials are expected in 2009.

-- MDX-1401 is a fully human antibody that targets CD30, a member of the TNF family expressed on CD30-positive lymphomas, including Hodgkin's lymphoma. MDX-1401 is a second-generation antibody enhanced for improved antibody effector function over the parental anti-CD30 antibody, MDX-060. Preliminary data from an ongoing Phase 1 trial of MDX-1401 is expected in 2008 at a medical conference, with final data expected in 2009.

-- MDX-1342 is a fully human antibody with enhanced antibody effector function that selectively binds to CD19, a molecule expressed on a broad range of B-cell malignancies. MDX-1342 also induces the depletion and elimination of B-cells for inflammatory disease indications. Phase 1 trials in chronic lymphocytic leukemia and rheumatoid arthritis are ongoing with data expected in 2009.

-- MDX-1411 is a fully human a
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
7. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
8. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
9. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
10. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
11. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... LONDON , April 24, 2015 ... leader in the development of biosimilar therapies, spoke about ... today at the European Generics Association (EGA) annual European ... The company also announced the publication of ... paramount to achieving the full promise of biosimilars." ...
(Date:4/23/2015)... -- Edwards Lifesciences Corporation (NYSE: EW ), the global ... monitoring, today reported net income for the quarter ended ... share.  Net income for the same period a year ... and non-GAAP net income was $82.1 million, or $0.76 ... quarter ended March 31, 2015 increased 13.0 percent to $590.3 ...
(Date:4/23/2015)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today ... financial results on Thursday, May 7, 2015, after the ... a live audio webcast immediately following the announcement at ... 2015 financial results and provide a business and financial ... audio webcast via the Investors & Media section of ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2
... June 4 After three long years of ... of Phoebe Sumter Medical Center welcomed the arrival of a ... Siemens Healthcare. The new MRI scanner premiered today at the ... destroyed the hospital in 2007. State and local political dignitaries ...
... Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary ... and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... version of Pfizer,s Neurontin® Tablets for the treatment of postherpetic neuralgia, ... Pharmaceuticals Inc. , , ...
Cached Medicine Technology:Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 2Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 3Mylan Receives Approval for Generic Version of Neurontin® Tablets 2
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog post that explains ... for flatbed trucks. , Flatbed trucks are used ... are mainly used for commercial purposes and thus require ... that by comparing multiple offers, drivers can find low ... , It is now possible to compare free online ...
(Date:4/25/2015)... Gardant Management Solutions will lead sessions ... and sales and marketing at the LeadingAge Illinois ... held from April 29 through May 1 in ... eldercare association in Illinois. The statewide association represents ... including senior housing, assisted living and supportive living ...
(Date:4/25/2015)... On Friday, April 17, Interstate Batteries was ... Implementation Award. This award is given to the ... RFID technology to improve its manufacturing, supply chain or ... demonstrates how RFID is delivering real value to shareholders. ... 2015 in San Diego, the RFID industries annual trade ...
(Date:4/24/2015)... Multi Customer Discount , Rules: This ... http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in Zeiter's Septics service ... does not include any Dig fees, or any other ... If someone is part of this group event and ... 2500 gallons or more, the cost would be $300.00. ...
(Date:4/24/2015)... Houston, TX (PRWEB) April 24, 2015 The ... Dan Long, after their great success of the Xtreme Fat ... the industry. The fat loss blueprint that claims to ... caught the attention of HealthyandFitZone.com's Stan Stevenson, prompting an investigative ... shows that the creators spent years researching and experimenting ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2
... executive, has warned that acute hospitals and Action and Emergency (A&E) ... health services deficit of ?512million. He added that ... may be combined in fewer units. ,He pointed out ... have to be maintained along with ...
... Tshwane University of Technology (TUT) have recommended shopping till ... not revenge on your husband or even your bank ... ,Department of sport and physical rehabilitation sciences ... the group of 40 students stumbled upon this finding ...
... has claimed 49 lives and affected 20,000 people in West ... Das told the West Bengal Assembly today. // ... as those of malignant malaria, Das said during mention hour., ... he said that it was far from adequate. Besides, there ...
... (INSH) ASHVINI located in Mumbai has been named the best ... ,Defence Minister Pranab Mukherjee awarded the Running trophy and a ... the hospital, Rear Admiral V K Saxena here today., ... functioning hospital among the Command Hospitals of the Indian Army ...
... moghul and UN Messenger for Peace, Vijay Amritraj, has ... India among HIV/AIDS victims. // ,The UN ... HIV/AIDS in India and only a fraction is getting ... medicines for the disease., ,Launching the `Amritraj Foundation' ...
... levels of benzene in two diet drinks, which has ... market. , ,The two drinks that have been ... Rose's Diabetic Squash Concentrate. Stricter guidelines have been enabled ... benzene formation in the drinks., ,Benzene, a ...
Cached Medicine News:
These are superior quality electrodes, fabricated from a single length of polyurethane tubing for strength and uniform smoothness. They are furnished with a specially-designed rigid stylet to facilit...
... Designed in collaboration with Drs. John R. ... Minnesota Epilepsy Group, Gates/Dunn electrodes are designed ... For cortical strip and grid electrodes, platinum ... surface, are individually numbered and have larger ...
...
... quality and design to provide you with ... Neurosurgeons worldwide consider these electrodes to be ... electrodes come in many useful standard configurations ... 64-contact grids. Their bodies are transparent so ...
Medicine Products: